Affibody News, Reviews & Resources

News and Trends 8 Mar 2023

Affibody and Chiesi Group to develop treatments for respiratory diseases

Affibody AB and Chiesi Farmaceutici S.p.A have announced a collaboration and licensing agreement to develop and commercialize innovative treatments for…

March 8, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 23 Dec 2022

Affibody signs €20 million loan agreement

Affibody Medical AB has received a €20 million ($21.2 million) venture debt loan facility from the European Investment Bank, EIB,…

December 23, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 8 Nov 2022

Rallybio announces positive phase 1 results for drug treating PNH and gMG

Affibody’s licensee Rallybio Corporation has announced positive topline results from a phase 1 single ascending dose (SAD) study in healthy…

November 8, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 22 Jun 2020

Swedish Biotech’s Psoriasis Drug Beats Placebo in Phase II

A new class of drug developed by the Swedish biotech company Affibody has proved better at treating symptoms of psoriasis…

June 22, 2020 - 3 minutesmins - By David Wilson

News and Trends 15 May 2020

Affibody Signs €208M Deal To Market Autoimmune Drug in China

Swedish biotech Affibody and Chinese firm Inmagene Biopharmaceuticals will work together to develop and commercialize Affibody’s phase II-stage drug for…

May 15, 2020 - 3 minutesmins - By Laura Cowen

Expert Advice 5 Nov 2019

How Sweden’s Intellectual Property Law Boosts Biotech Innovation

Founding one biotech company and making a success of it is difficult enough, but Mathias Uhlén has founded 20. Not…

November 5, 2019 - 10 minutesmins - By Helen Albert

Resources

Categories

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

The Biotech Perspective 2023

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

Americas

Asia Pacific

Europe

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Company

Join Us

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering